Advance Search
XU Shao-hua, CHENG Wen-jun, XU Pei-zhen. Expression of microRNA- 200a and its clinical significance in ovarian epithelial cancer[J]. Journal of Clinical Medicine in Practice, 2012, (15): 47-49,53.
Citation: XU Shao-hua, CHENG Wen-jun, XU Pei-zhen. Expression of microRNA- 200a and its clinical significance in ovarian epithelial cancer[J]. Journal of Clinical Medicine in Practice, 2012, (15): 47-49,53.
shu

Expression of microRNA- 200a and its clinical significance in ovarian epithelial cancer

More Information
  • Published Date: December 19, 2012
    Graphical Abstract
    • Abstract
    • FullText(HTML)
    • References (20)
  • Fung-Kee-Fung M, Oliver T, Elit L. Optimal chemotherapy treatment for women with recurrent ovarian cancer [J]. Curr Oncol, 2007(5):195.
    Barrel D P. MicroRNAs:genomics, biogenesis, mechanism, and function [J]. Cell, 2004(2):281.
    Esquela-Kerscher A, Slack F J. Oncomirs-microRNAs with a role in cancer [J]. Nature Reviews Cancer, 2006(4):259.
    Shinozaki A, Sakatani T, Ushiku T. Downregulation of microRNA-200 in EBV-associated gastric carcinoma [J]. Cancer Research, 2010, (11):4719.
    Murakami Y, Yasuda T, Saigo K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues [J]. Oncogene, 2006, (17):2537.
    Braun J, Hoang Vu C, Dralle H. Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas [J]. Oncogene, 2010, (29):4237.
    Xia H, Ng S S, Jiang S. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion [J]. Biochemical and Biophysical Research Communications, 2010(1):535.
    Liu H, Brannon A R, Reddy A R. Identifying mRNA targets of microRNA dysregulated in cancer:with application to clear cell Renal Cell Carcinoma [J]. BMC Syst Biol, 2010.51.
    Iorio M V, Visone R, Di L G. MicroRNA signatures in human ovarian cancer [J]. Cancer Research, 2007, (18):8699.
    Nam E J, Yoon H, Kim S W. MicroRNA expression profiles in serous ovarian carcinoma [J]. Clinical Cancer Research, 2008(9):2690.
    Dahiya N, Sherman-Baust CA, Wang TL. MicroRNA expression and identification of putative miRNA targets in ovarian cancer [J]. PLOSONE, 2008(6):e2436.
    Hu X, Macdonald D M, Huettner P C. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer [J]. Gynecologic Oncology, 2009(3):457.
    Fuchs I B, Lichtenegger W, Buehler H. The prognostic significance of epithelial-mesenchymal transition in breast cancer [J]. Anticancer Research, 2002, (6A):3415.
    Aigner K, Dampier B, Descovich L. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity [J]. Oncogene, 2007, (49):6979.
    Christoffersen N R, Silahtaroglu A, Orom U A. miR-200b mediates post-transcriptional repression of ZFHX1B [J]. RNA-A PUBLICATION OF THE RNA SOCIETY, 2007(8):1172.
    Park SM, Gaur AB, LengyelE. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 [J]. Genes and Development, 2008(7):894.
    Gregory P A, Bert A G, Paterson E L. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 [J]. Nature Cell Biology, 2008(5):593.
    Sivertsen S, Bemer A, Michael C W. Cadherin expression in ovarian carcinoma and malignant mesothelioma cell effusions [J]. Acta Cytologica, 2006(6):603.
    Landen CN Jr, Birrer M J, Sood A K. Early events in the pathogenesis of epithelial ovarian cancer [J]. Journal of Clinical Oncology, 2008(6):995.
    Bracken C P, Gregory P A, Kolesnikoff N. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition [J]. Cancer Research, 2008, (19):7846.
    • Related Articles

  • Related Articles

    [1]JI Chao, CHEN Yixiao, LIU Kai, SU Xiaochen, TENG Menghao, GUO Yan, JI Wenchen, LI Meng. Screening of diagnostic biomarkers and their relations with immune cell infiltration in osteoporosis[J]. Journal of Clinical Medicine in Practice, 2023, 27(15): 1-6. DOI: 10.7619/jcmp.20231718
    [2]ZHANG Yuanchun, ZHAO Cuiping, JIN Wenli, ZHANG Haiyan, LIU Jining, HAN Jingjing, LIU Meixia, LIU Zhengtang. Curative effect of Chinese herbal ointment and massage on lumbago and back pain in senile osteoporosis patients[J]. Journal of Clinical Medicine in Practice, 2023, 27(1): 92-95. DOI: 10.7619/jcmp.20222714
    [3]HUANG Wei, WANG Xu, SHEN Zhimei, CUI Fei. Research progress on mechanism of action of stromal cell derived factor-1 in osteoporosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 144-148. DOI: 10.7619/jcmp.20222400
    [4]ZHU Fei, YONG Jiacheng, CHEN Hao, YU Xiaoping, JIAO Xiuping, SHAN Qing. Correlation between glomerular filtration rate and osteoporosis in physical examination population[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 28-33, 40. DOI: 10.7619/jcmp.20221876
    [5]BAO Huhe, SUN Guanwen, WANG Jian, JIA Peng, HU He. Efficacy observation on sequential therapy with teriparatide and bisphosphonates for senile patients with osteoporosis[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 95-98. DOI: 10.7619/jcmp.20211522
    [6]DONG Hui, YU Hang, WANG Yongxiang. Research progress in role and mechanism of circular RNA in osteoporosis[J]. Journal of Clinical Medicine in Practice, 2021, 25(4): 111-115. DOI: 10.7619/jcmp.20210167
    [7]LI Xiaohua, HUANG Xiaohong. Relaxation therapy combined with pain nursing intervention in elderly patients with osteoporosis[J]. Journal of Clinical Medicine in Practice, 2020, 24(18): 129-132. DOI: 10.7619/jcmp.202018035
    [8]CHEN Li, WANG Gang. The application of integrated health education in the elderly with osteoporosis in community[J]. Journal of Clinical Medicine in Practice, 2016, (22): 47-50. DOI: 10.7619/jcmp.201622015
    [9]LUO Zhanpeng, WANG Liang, XU Xiaowen, YANG Fan, MA Yuanzheng. Effect assessment of osteoporosis health education and movement instruction based on the digital platform[J]. Journal of Clinical Medicine in Practice, 2016, (13): 73-76,86. DOI: 10.7619/jcmp.201613021
    [10]SUN Xia. Risk factors assessment of re-fracture in elderly patients with osteoporosis and its nursing intervention[J]. Journal of Clinical Medicine in Practice, 2016, (2): 80-82,92. DOI: 10.7619/jcmp.201602025

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by()
    Turn off MathJax
    Article Contents
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return